Definition
- Benign salivary gland tumour
Epidemiology
- Rare <1%
- 2nd most common benign parotid gland tumour
- M>F
Risk Factor
- SMOKING (only salivary gland tumour associated to smoking)
- Others
Location
- Parotid (almost exclusively)
Features
- Commonly cystic and bilateral
Pathology
- Macro
- Well circumscribed mass
- Solid and cystic components
- Micro
- Bilayered oncocytic epithelium
- Cyst formation
- Lymphoid stroma
Clinical
- Painless lump near angle of mandible
Investigations
- Assess both sides - bilaterality and multiple
- USS - well defined mass, anechoic areas, post acoustic shadowin
- CT - bony involvement
- MRI - soft tissue involvement, encapsulated, hypo T1
- Biopsy - FNA or core
Management
- Usually superficial parotidectomy
- Surveillance if biopsy proven and not changing, asymptomatic
- Low recurrence rate and minimal malignant potential
Spiel on Warthin’s tumour
- 2nd most common benign salivary tumour
- Affects almost exclusively the parotid gland
- Typified by bilayered oncocytic epithelium, cyst formation and lymphoid stroma
- RF - SMOKING, prior RTX, viral (EBV/HPV/HIV) and exposures - nickel, rubber, hairdresser
- Minimal risk of malignant transformation
- Can avoid surgery and monitor if no sx
- Presents with painless lump
- Work up with USS/CT/MRI and FNA/core
- Mx is superficial parotidectomy and facial nerve preservation
- Minimal benefit for doing total even if deep component is involved